Create a free QxMD account to take advantage of the features offered by Read like saving your papers and creating collections.

Get Started

LETTER

Home treatment of hereditary angioedema with icatibant administered by health care professionals

Henriette Farkas, Dorottya Csuka, Zsuzsanna Zotter, Lilian Varga, Zoltán Böröcz, György Temesszentandrási, László Jakab, István Karádi

Journal of Allergy and Clinical Immunology 2012, 129 (3): 851-852.e2

No abstract text is available yet for this article.

Full Text Links

Find Full Text Links for this Article

Discussion

You are not logged in. Sign Up or Log In to join the discussion.

Related Papers

Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report. D Firinu, M P Barca, L Serusi, M M Lorrai, M M Peralta, P E Manconi, S R Del Giacco International Journal of Immunopathology and Pharmacology 2012, 25 (1): 269-73

Hereditary angioedema--therapies old and new. B Paul Morgan New England Journal of Medicine 2010 August 5, 363 (6): 581-3

Icatibant for hereditary angioedema. Jordi Gras Drugs of Today 2009, 45 (12): 855-64

Icatibant. Eline A Dubois, Adam F Cohen British Journal of Clinical Pharmacology 2010, 69 (5): 425-6

Management of acute attacks of hereditary angioedema: potential role of icatibant. Hilary J Longhurst Vascular Health and Risk Management 2010, 6: 795-802

Hereditary angioedema therapies in the United States: movement toward an international treatment consensus. Marc Riedl Clinical Therapeutics 2012, 34 (3): 623-30

Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. William R Lumry, H Henry Li, Robyn J Levy, Paul C Potter, Henriette Farkas, Dumitru Moldovan, Marc Riedl, Hongbin Li, Timothy Craig, Bradley J Bloom, Avner Reshef Annals of Allergy, Asthma & Immunology 2011, 107 (6): 529-37

Therapeutic agents for hereditary angioedema. Pedro Giavina-Bianchi, Abílio Motta, Jorge Kalil New England Journal of Medicine 2011 January 6, 364 (1): 85; author reply 86

Successful treatment of hereditary angioedema with bradykinin B2-receptor antagonist icatibant. Karoline Krause, Martin Metz, Torsten Zuberbier, Marcus Maurer, Markus Magerl Journal der Deutschen Dermatologischen Gesellschaft: JDDG 2010, 8 (4): 272-4

Therapeutic potential of icatibant (HOE-140, JE-049). Nicholas L M Cruden, David E Newby Expert Opinion on Pharmacotherapy 2008, 9 (13): 2383-90

Make the most of Read.
Download the mobile app.

Want full text access to this paper?

Use Read by QxMD to access full text via your institution or open access sources.

Read also provides personalized recommendations to keep you up to date in your field.

Existing User

New to Read

Home treatment of hereditary angioedema with icatibant administered by health care professionals

Discussion

Related Papers

Want full text access to this paper?

Save your favorite articles in one place with a free QxMD account.

Read

Search Tips